New York Times, October 13, 2021 (with Noah Weiland)

Link

People who received a Johnson & Johnson coronavirus vaccine may be better off with a booster shot from Moderna or Pfizer-BioNTech, according to preliminary data from a federal clinical trial published on Wednesday.

That finding, along with a mixed review by the Food and Drug Administration of the case made by Johnson & Johnson for an authorization of its booster, could lead to a heated debate about how and when to offer additional shots to the 15 million Americans who have received the single-dose vaccine.

Continue reading “People who received a J.&J. vaccine may be better off with a Moderna or Pfizer booster, a study finds.”

New York Times, October 12, 2021

Link

The German company CureVac announced on Tuesday that it was withdrawing its mRNA vaccine for Covid-19 from the approval process in Europe. The company pulled the plug after determining that it might take until June for regulators to make a ruling about the vaccine.

With other mRNA vaccines from Moderna and Pfizer-BioNTech already in wide distribution, the company decided it was time to give up on its initial efforts to address the Covid-19 emergency.

Continue reading “CureVac has withdrawn its Covid vaccine application to European regulators.”

New York Times, October 9, 2021

Link

As the world grapples with Covid-19, influenza isn’t getting much attention these days. But the flu’s global impact is staggering: three million to five million cases of severe illness every year, and up to 650,000 deaths. Every few decades, a new flu strain spills over from animals and leads to a pandemic.

The deadly toll of influenza is all the more striking when you consider that we have had vaccines to fight it for eight decades. But they remain mediocre. A flu shot is good for only one flu season, and its effectiveness typically reaches somewhere between 40 and 60 percent. In some years it’s as low as 10 percent.

Continue reading “First, Impressive Vaccines for Covid. Next Up: The Flu.”

New York Times, September 30, 2021

Link

A British clinical trial found no sign of danger in getting a flu shot and a second dose of a Covid-19 vaccine at the same time, results that support the advice of U.S. health authorities and are welcome news for strained health care workers as flu season hits.

In the study, doctors recruited 679 people from April to June across Britain. At the time, all of the volunteers had received a first dose of a Covid-19 vaccine, either from AstraZeneca or Pfizer-BioNTech, the two vaccines first authorized there.

Continue reading “A study finds no signs of trouble in getting flu and Covid shots at the same time.”

The New York Times, September 23, 2021

Link

Ancient human footprints preserved in the ground across the White Sands National Park in New Mexico are astonishingly old, scientists reported on Thursday, dating back about 23,000 years to the Ice Age.

The results, if they hold up to scrutiny, would rejuvenate the scientific debate about how humans first spread across the Americas, implying that they did so at a time when massive glaciers covered much of their path.

Researchers who have argued for such an early arrival hailed the new study as firm proof.

Continue reading “Ancient Footprints Push Back Date of Human Arrival in the Americas”